Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: NMPA GMP (China)

The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing

Posted on January 1, 2025 By digi

The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing What Lies Ahead: The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing Introduction to Evolving MHRA GMP Regulations The pharmaceutical industry is undergoing rapid transformation driven by advancements in technology, evolving patient needs, and increasing regulatory scrutiny. The Medicines and…

Read More “The Future of MHRA GMP Regulations and Their Impact on Pharma Manufacturing” »

MHRA GMP Guidelines

How to Address Non-Conformities Identified During NMPA GMP Inspections

Posted on January 1, 2025 By digi

How to Address Non-Conformities Identified During NMPA GMP Inspections How to Address Non-Conformities Identified During NMPA GMP Inspections Introduction to NMPA GMP Inspections Ensuring compliance with Good Manufacturing Practices (GMP) is a key aspect of the pharmaceutical industry’s responsibility to maintain product quality, safety, and efficacy. In China, the National Medical Products Administration (NMPA), formerly…

Read More “How to Address Non-Conformities Identified During NMPA GMP Inspections” »

NMPA GMP Guidelines

How WHO GMP Guidelines Impact the Production of Vaccines

Posted on January 1, 2025 By digi

How WHO GMP Guidelines Impact the Production of Vaccines The Role of WHO GMP Guidelines in Ensuring Vaccine Quality and Safety Introduction to WHO GMP and Vaccine Production Vaccines are a cornerstone of global health, preventing the spread of infectious diseases and saving millions of lives annually. The complexity of vaccine production, however, demands rigorous…

Read More “How WHO GMP Guidelines Impact the Production of Vaccines” »

WHO GMP Guidelines

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance

Posted on December 31, 2024 By digi

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance Introduction to Regulatory Harmonization and Its Importance Regulatory harmonization refers to the process of aligning the regulatory requirements of different countries or regions to ensure consistency, mutual recognition, and efficiency in regulatory practices….

Read More “The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance” »

GMP in Latin America (ANVISA, COFEPRIS)

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing

Posted on December 31, 2024 By digi

Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing Leveraging Technology to Comply with Schedule M (Revised) GMP in Pharmaceutical Manufacturing Introduction to Technology in Pharmaceutical GMP Pharmaceutical manufacturing has evolved significantly with advancements in technology. As regulations become more stringent, technology plays an indispensable role in ensuring compliance with Good Manufacturing…

Read More “Schedule M (Revised) GMP and the Role of Technology in Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

How to Align TGA GMP with Other International Drug Regulatory Guidelines

Posted on December 31, 2024 By digi

How to Align TGA GMP with Other International Drug Regulatory Guidelines Strategies for Aligning TGA GMP with Global Pharmaceutical Regulatory Standards Introduction to TGA GMP and International Standards Pharmaceutical manufacturing is a global industry, with products often crossing borders before reaching consumers. The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practices (GMP) in Australia to…

Read More “How to Align TGA GMP with Other International Drug Regulatory Guidelines” »

TGA GMP Guidelines

How to Address Non-Conformities Identified During PMDA GMP Inspections

Posted on December 31, 2024 By digi

How to Address Non-Conformities Identified During PMDA GMP Inspections How to Address Non-Conformities Identified During PMDA GMP Inspections Introduction to PMDA GMP Inspections The Pharmaceutical and Medical Devices Agency (PMDA) enforces Good Manufacturing Practices (GMP) in Japan to ensure that pharmaceutical products are consistently produced and controlled according to high standards of safety, efficacy, and…

Read More “How to Address Non-Conformities Identified During PMDA GMP Inspections” »

PMDA GMP Guidelines

How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access

Posted on December 31, 2024 By digi

How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access Achieving Global Market Access Through WHO GMP Compliance Introduction to WHO GMP and Global Market Access Pharmaceutical companies aiming to expand their presence in international markets must meet stringent regulatory requirements to ensure the safety, quality, and efficacy of their products. The World Health…

Read More “How WHO GMP Guidelines Help Pharmaceutical Companies Achieve Global Market Access” »

WHO GMP Guidelines

How to Implement Continuous Improvement for MHRA GMP Compliance

Posted on December 31, 2024 By digi

How to Implement Continuous Improvement for MHRA GMP Compliance Continuous Improvement Strategies for MHRA GMP Compliance Introduction to Continuous Improvement and MHRA GMP Continuous improvement is a fundamental concept in maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP). As regulatory requirements evolve and new challenges emerge, pharmaceutical companies…

Read More “How to Implement Continuous Improvement for MHRA GMP Compliance” »

MHRA GMP Guidelines

NMPA GMP and the Manufacture of Biologics

Posted on December 31, 2024 By digi

NMPA GMP and the Manufacture of Biologics NMPA GMP and the Manufacture of Biologics Introduction to NMPA GMP and Biologics Biologics are a rapidly growing segment of the pharmaceutical industry, encompassing a wide range of products, from vaccines and blood products to monoclonal antibodies and gene therapies. Given their complexity and the critical role they…

Read More “NMPA GMP and the Manufacture of Biologics” »

NMPA GMP Guidelines

Posts pagination

Previous 1 … 14 15 16 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme